American Health Packaging recalls Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American Health Packaging, Columbus, Ohio…
Labeling: Label Mix-up
Read the official notice →- Date
- 2026-09-09
- Country
- United States
- Brand
- American Health Packaging
- Product
- Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American Health Packaging, Columbus, Ohio…
- Classification
- Class III
- Units
- US Nationwide.
- Category
- Drugs & medical
- Source
- FDA · Drug
Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the product name, strength and lot number against the official notice.
- Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
- Ask the pharmacy or supplier about a replacement or refund.
General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.
More American Health Packaging recalls
- 2022-05-25
USAmerican Health Packaging recalls Nitrofurantoin Capsules, USP (Monohydrate/Macrocrystals), 100 mg, 100 Capsules (10 x 10), 10-count blisters per card, 10 cards per…
Failed Dissolution Specifications: Nitrofurantoin Capsules recalled due to dissolution failure at 0-time of the repackaged lot. Drug release results were above specification at 0-time.
- 2022-05-04
- US
American Health Packaging recalls Cyanocobalamin Injection, USP, 1000 mcg per mL, For Intramuscular or Subcutaneous Use Only, 25 x 1 mL Vials, Rx only, Manufactured by:…
Subpotent Drug: Out of specification for assay.
- 2022-03-16
- US
American Health Packaging recalls Oxycodone Hydrochloride Oral Solution, USP (C-II), 5 mg/5 mL, Delivers 5 mL per Cup, 1 Tray of 10 Cups, Rx Only, For Institutional Use…
Impurity failure at 0-time of the repackaged lot.
- 2022-02-02
- US
- 2021-10-27
- US
American Health Packaging recalls GlipiZIDE Extended-Release Tablets, 2.5 mg, 30 Tablets (3 blister cards each with 10 individually blistered doses), Rx only,…
Failed Dissolution Specifications: results were above specification.
- 2021-10-06
- US
American Health Packaging recalls Valproic Acid Oral Solution, USP, 500 mg/10 mL, 100 10 mL unit dose cups per case, Rx Only, Packaged and Distributed by: American…
CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contaminated with microbial organisms.
Other drugs & medical recalls in the United States
- 2026-09-09
- US
OPTIMAL BALANCE PHARMACY recalls Glutathione 200 mg/mL, 30 mL sterile multidose vial, Each vial contains: Glutathione, Ascorbic Acid, Benzyl Alcohol & sterile water for…
Microbial Contamination of Sterile Products - out of specifications results were obtained for bacterial endotoxin.
- US
Baxter Healthcare Corporation recalls 0.9% Sodium Chloride Injection USP 500 mL, VIAFLEX Plastic Containers, with 24 units per case. Baxter Healthcare Corporation,…
Presence of particulate matter: Particulates identified as fiberglass
- US
Golden State Medical Supply Inc. recalls Prasugrel HCI, Tablets, USP, 10mg, 30-count bottle, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CA 93012, USA, NDC:…
Failed Dissolution Specifications. Notification from the manufacturer that lot is being recalled due to failed dissolution
- US
Mylan Pharmaceuticals Inc recalls Prasugrel Tablets, USP, 10mg, Rx only, 30 Tablets in each bottle, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505,…
Failed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteria
- US
Chiesi USA, Inc. recalls Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx Only, For Intramuscular Use Only, Mfd. by Chiesi…
Failed Stability Specifications: Out of specification stability result for the protein concentration profile.
- US